Researchers have uncovered a troubling connection between the bacteria that cause gum disease and a serious, potentially life-threatening heart condition. New preliminary findings suggest that Porphyromonas gingivalis, a bacterium responsible for periodontal disease, may trigger calcium buildup in the aortic valve, leading to calcific aortic valve stenosis (CAVS).
The discovery emerged from laboratory and animal studies presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2026 in Boston. Scientists analyzed valve tissue from patients undergoing heart surgery and found unexpectedly high levels of the gum disease bacterium in calcified aortic valves compared to healthy valve tissue.
CAVS develops when the aortic valve gradually thickens and calcifies, restricting blood flow from the heart to the body. The condition often progresses silently at first. As it advances, patients may experience fatigue, chest pain, shortness of breath, and fainting. Severe cases can lead to heart failure or death. Valve replacement surgery is currently the only definitive treatment.
"We were surprised by how much P. gingivalis was present in the calcified aortic valves," said Chenyang Li, a co-lead researcher with China's Fuwai Hospital. "Although it was not one of the most abundant bacteria overall, it showed one of the largest differences between valves with CAVS and valves without CAVS."
To understand the mechanism, researchers exposed mice to live and inactivated versions of the bacterium. Repeated exposure to live P. gingivalis caused the bacteria to accumulate in mouse aortic valves, increasing calcium deposits and producing aortic stenosis symptoms. Preventive antibiotic treatment reduced these harmful effects.
The team identified the biological pathway involved. The gum disease bacterium activated interleukin-1 beta (IL-1b), an inflammation-promoting protein. When researchers genetically deleted IL-1b in mice, valve calcification and disease symptoms dropped significantly, even with P. gingivalis present. This finding suggests the inflammatory response, not the bacteria alone, drives the valve damage.
The implications are striking because no medications currently exist to prevent or slow CAVS progression. The discovery opens a potential new avenue for treatment and prevention.
"There are currently no medications proven to prevent or slow the progression of CAVS," Li said. "We hope our findings will stimulate further research into new preventive and therapeutic approaches for this condition."
The oral-cardiac connection has broad public health relevance. Eduardo Sanchez, chief medical officer for prevention at the American Heart Association, emphasized that dental visits often represent a patient's only touchpoint with healthcare. "That makes dental professionals important partners in spotting health conditions, including periodontal disease early," Sanchez said.
For now, the message is straightforward: maintain good oral hygiene. Brushing, flossing, and regular dental visits may protect not only teeth and gums but also the heart. The American Heart Association supports this connection through its Healthy Smiles, Healthy Hearts initiative, which provides dental professionals with resources on the link between oral and cardiovascular health.
Researchers caution that these findings remain preliminary. The work was presented as a conference abstract and has not yet undergone peer review or full publication. The team has launched a clinical study in humans to confirm whether the same connection exists in people. Until those results arrive, the discovery stands as compelling laboratory evidence that treating gum disease may eventually become part of heart disease prevention strategy.
Author Jessica Williams: "This research shouldn't trigger alarm about every case of gum disease turning into heart trouble, but it's a solid reminder that what happens in your mouth doesn't stay in your mouth."
Comments